Home › Bladder Cancer › Delaware › Newark
Bladder Cancer clinical trials in Newark, DE
4 studies for Bladder Cancer are looking for participants at sites in and around Newark (within about 30 miles). Open a study to see who can join and how to contact the study team.
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial
RecruitingPhase 2
- Helen F Graham Cancer Center, Newark
- Medical Oncology Hematology Consultants PA, Newark
Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)
RecruitingPhase 3
- Medical Oncology Hematology Consultants, Newark
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
RecruitingPhase 3
- Helen F Graham Cancer Center, Newark
- Medical Oncology Hematology Consultants PA, Newark
- Christiana Care Health System-Christiana Hospital, Newark
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecruitingObservational study
- Massive Bio SYNERGY-AI site, Newark
About Bladder Cancer
Bladder cancer symptoms range from lower back pain to blood in your urine. Read about important risk factors and find a list of treatments available
More about Bladder Cancer on MedlinePlus
Bladder Cancer trials in other cities
- New York City, NY34 studies
- Nashville, TN31 studies
- Houston, TX31 studies
- Boston, MA27 studies
- Dallas, TX27 studies
- Washington, DC26 studies
- Los Angeles, CA24 studies
- Baltimore, MD24 studies
- St. Louis, MO22 studies
- Edison, NJ22 studies
- Seattle, WA21 studies
- Philadelphia, PA21 studies
Other studies in Newark
- Non-Small Cell Lung Cancer16 studies
- Colorectal Cancer9 studies
- Lung Cancer9 studies
- Prostate Cancer9 studies
- Breast Cancer8 studies
- Cancer (all types)7 studies
- Metastatic Cancer7 studies
- Pancreatic Cancer6 studies
- Endometrial Cancer5 studies
- Ovarian Cancer5 studies
- Melanoma4 studies
- Follicular Lymphoma4 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.